This approach is recently explored using a microfluidic immuno-array for the rapid and low-cost detection of a carbohydrate (CA153 and CAA155) and carcinoembryonic antigen (CEA 153) in breast cancer. The gene discussed is CEACAM5; the disease is breast cancer.